James J, Albertine
Co-Founder & President Albertine Enterprises Inc
James J. Albertine is a prominent leader in public policy, lobbying, and government relations, known for his expertise in public finance and securing funding from government sources. As the President of Albertine Enterprises, Inc. (AEI), he has cultivated a reputation for guiding clients through complex regulatory landscapes and helping them achieve legislative success. AEI has become synonymous with effective advocacy and strategic counsel, particularly in sectors like biotechnology, defense, and healthcare.
Before founding AEI, Mr. Albertine’s career was defined by high-impact leadership roles. He served as the President of the American League of Lobbyists, where he earned recognition as one of the most respected lobbyists in Washington, D.C. His time leading the organization helped define best practices within the lobbying industry. He also served as the Senior Vice President of the American Health Care Association (AHCA), where he tackled critical health policy issues at the national level. His deep understanding of healthcare regulations and funding channels has shaped AEI’s approach to policy advocacy in the sector.
Additionally, Mr. Albertine was the Director of Government Affairs for the American Society of Association Executives (ASAE). In this role, he led efforts to influence federal policy for more than 19,000 associations across a wide array of industries, strengthening his ability to shape public policy on behalf of a diverse range of stakeholders.
Before founding AEI, Mr. Albertine’s career was defined by high-impact leadership roles. He served as the President of the American League of Lobbyists, where he earned recognition as one of the most respected lobbyists in Washington, D.C. His time leading the organization helped define best practices within the lobbying industry. He also served as the Senior Vice President of the American Health Care Association (AHCA), where he tackled critical health policy issues at the national level. His deep understanding of healthcare regulations and funding channels has shaped AEI’s approach to policy advocacy in the sector.
Additionally, Mr. Albertine was the Director of Government Affairs for the American Society of Association Executives (ASAE). In this role, he led efforts to influence federal policy for more than 19,000 associations across a wide array of industries, strengthening his ability to shape public policy on behalf of a diverse range of stakeholders.
Mr. Albertine’s expertise in public finance has been key to AEI’s success in securing critical funding for clients. His ability to raise funds from federal sources, such as the Department of Defense, Department of Energy, Health and Human Services (HHS), and Department of Homeland Security (DHS), has enabled businesses to grow and innovate. For instance, Mr. Albertine was instrumental in securing funding for a U.S. manufacturer of all-terrain vehicles (ATVs), enabling them to develop new products in collaboration with the Department of Defense.
He is also actively working in the biotechnology sector, currently seeking funding from HHS and DHS for the development of a medical compound aimed at countering multi-drug-resistant tuberculosis (MDRTB)—a critical area of focus, particularly in light of potential bioterrorism threats. This work underscores Mr. Albertine’s ongoing commitment to addressing global health security issues and advancing innovation in healthcare.
Through his leadership at AEI, Mr. Albertine continues to influence policy and secure essential funding for businesses and organizations navigating both domestic and international regulatory challenges. His deep experience in public policy, government affairs, and fundraising ensures that AEI remains a trusted partner for clients across a variety of industries.
He is also actively working in the biotechnology sector, currently seeking funding from HHS and DHS for the development of a medical compound aimed at countering multi-drug-resistant tuberculosis (MDRTB)—a critical area of focus, particularly in light of potential bioterrorism threats. This work underscores Mr. Albertine’s ongoing commitment to addressing global health security issues and advancing innovation in healthcare.
Through his leadership at AEI, Mr. Albertine continues to influence policy and secure essential funding for businesses and organizations navigating both domestic and international regulatory challenges. His deep experience in public policy, government affairs, and fundraising ensures that AEI remains a trusted partner for clients across a variety of industries.